Menu Search
Equities

Athanase Innovation AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
H6H:FRA

Athanase Innovation AB

Actions
  • Price (EUR)1.08
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-36.84%
  • Beta--
Data delayed at least 15 minutes, as of Feb 12 2026 07:55 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Athanase Innovation AB is a Sweden-based company primarily engaged in the financial services industry. The Company focuses on investing in early-stage companies with technologies in sectors such as life sciences, software, and clean technology. Athanase Innovation AB key product is the investment portfolio, which is a collection of equity investments in companies. It aims to create long-term value for investors by supporting the growth and development of technology and innovation companies. Athanase Innovation AB utilizes various technologies, including Artificial Intelligence (AI), to enhance their investment strategies. The Company is committed to fostering innovation and driving progress in emerging industries.

  • Revenue in SEK (TTM)49.39m
  • Net income in SEK-50.43m
  • Incorporated2017
  • Employees31.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.